Clinical Trials Directory

Trials / Unknown

UnknownNCT01646801

Study of NMB Drug Ejecting Balloon for Peripheral Arteries

The Use of NMB Drug Ejecting Balloon for Treatment of Patients With Peripheral Arterial Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
N.M.B. Medical Applications Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate the Safety and effectiveness of the use of NMB's drug ejecting balloon for the treatment of de novo and restenotic lesions in peripheral arterial disease.

Conditions

Interventions

TypeNameDescription
DEVICENMB Balloon Catheterpatients treated by the NMB's Drug Ejecting Balloon

Timeline

Start date
2013-01-01
Primary completion
2014-01-01
Completion
2015-01-01
First posted
2012-07-20
Last updated
2012-07-24

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01646801. Inclusion in this directory is not an endorsement.

Study of NMB Drug Ejecting Balloon for Peripheral Arteries (NCT01646801) · Clinical Trials Directory